North Landing Financial Partners, LLC Merck & Co., Inc. Transaction History

North Landing Financial Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $146,895 - $163,905	-1,427 Reduced 34.09%	2,759 $293,000
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $239,148 - $306,620	-2,735 Reduced 39.52%	4,186 $464,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $585,032 - $657,218	6,921 New	6,921 $596,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of North Landing Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on North Landing Financial Partners, LLC with notifications on news.